Skip to main content
SpringerLink
Log in

Effect of pituitary ultrasonic treatment on plasma human growth hormone levels in diabetic retinopathy and acromegaly

  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

Sixteen diabetic patients presenting advanced retinopathy and 6 patients with acromegaly underwent ultrasonic treatment (UST) of the pituitary, according to Arslan’s method. In the diabetic retinopathy patients, circadian variations of plasma human growth hormone (HGH) levels were studied as well as the response to insulin stimulation, previous to and 7 days after the operation. Five patients were also studied 3 months post-ultrasonic treatment. Preoperative HGH plasma levels were normal and no reduction was observed following operation. Acromegalic patients were rested for oral glucose tolerance and insulin response, before and 7 days after operation. High pre-operatory HGH levels fell appreciably after operation, but the reduction was not significant. Our data demonstrate that high plasma levels of HGH are not always found in diabetes and that even after UST of the pituitary, there does not seem to be a relationship between degree of pituitary inhibition and clinical results. On the other hand, ultrasonic treatment of the pituitary in acromegalic patients determines partial hypophyseal inhibition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adams D. A., Rand R. W., Roth N. H., Dashe A. M., Heuser G., Hanley Y., Parker M.: Cryoablation of the Pituitary in the Treatment of Progressive Diabetic Retinopathy — Diabetes17, 634, 1968.

    PubMed  CAS  Google Scholar 

  2. Arslan M.: Prime applicazioni del metodo di distruzione ultrasonica dell’ipofisi per via transetmoidale — Acta isotop.4, 417, 1964.

    CAS  Google Scholar 

  3. Arslan M., Crepaldi G., Grandesso R., Molinari G. A., Muggeo M., Ricci V.: Direct Ultrasonic Irradiation of the Hypophysis — Ed. Piccin, Padova, 1973; p. 99.

    Google Scholar 

  4. Boden G., Balodimos M. C., Jacobs M., Rees S. B., Bradley R. F.: The Effect of Hypophysectomy, Hypophyseal Stalk Section and Proton Beam Irradiation on Human Growth Hormone Secretion in Retinitis Proliferans — Diabetes17 (Suppl. 1), 318, 1968.

    Google Scholar 

  5. Canivet J., Regnault F., Passa P.: Indications et résultats du traitment par hypophysectomie de la rétinopathie diabétique — Journées Annuelles de Diabétologie de l’Hôtel-Dieu, Paris 1971. Flammarion Éd., Paris, 1971; p. 213.

  6. Field R. A., Schepens C. L., Sweet W. H., Appels A.: The Effect of Hypophyseal Stalk Section on Advancing Diabetic Retinopathy: Report of Thirteen Cases — Diabetes11, 465, 1962.

    PubMed  CAS  Google Scholar 

  7. Glick S. M., Roth J., Yalow R. S., Berson S. A.: The Regulation of Growth Hormone Secretion — Recent Progr. Hormone Res.21, 241, 1965.

    PubMed  CAS  Google Scholar 

  8. Hardy J., Ciric I. S.: Selective Anterior Hypophysectomy in the Treatment of Diabetic Retinopathy: a Transsfenoidal Micro-Surgical Technique — J. Amer. med. Ass.203, 73, 1968.

    Article  CAS  Google Scholar 

  9. Joplin G. F., Oakley N. W., Hill D. W., Kohner E. M., Fraser T. R.: Diabetic Retinopathy. II. Comparison of Disease Remission Induced by Various Degrees of Pituitary Ablation by Y90 — Diabetologia3, 406, 1967.

    Article  PubMed  CAS  Google Scholar 

  10. Lawrence A. M., Pinsky S. M., Goldfine I. D.: Conventional Radiation Therapy in Acromegaly: a Review and Reassessment — Arch. intern. Med.128, 369, 1971.

    Article  PubMed  CAS  Google Scholar 

  11. Lawrence J. H., Tobias C. A., Linfoot J. A., Born J. L., Gottschalk A., Kling R. P.: Heavy Particles, the Bragg Curve and Suppression of Pituitary Function in Diabetic Retinopathy — Diabetes12, 490, 1963.

    PubMed  CAS  Google Scholar 

  12. Linfoot A. J., Garcia F. J., Hoye A. S., Schmitt J., Lawrence H. J.: Heavy Particle Therapy in Acromegaly — Proc. roy. Soc. Med.63, 219, 1970.

    PubMed  CAS  Google Scholar 

  13. Luft R.: Indications That Human Growth Hormone Plays a Role in Diabetes Mellitus and Diabetic Retinopathy — In:Leibel B. S., Wrenshall G. A. (Eds): On the Nature and Treatment of Diabetes. Congress Series 84, Excerpta Medica Foundation, Amsterdam, 1965; p. 498.

    Google Scholar 

  14. Luft R., Olivecrona H., Sjögren B.: Hypophysectomy in Man: Experiences in Severe Diabetes Mellitus — J. clin. Endocr.15, 391, 1955.

    Article  PubMed  CAS  Google Scholar 

  15. Lundbæk K., Christensen N. J., Jensen V. A., Johansen K., Olsen T. S., Hansen Aa. P., Ørskov H., Østerby R.: The Pathogenesis of Diabetic Angiopathy and Growth Hormone — Dan. med. Bull.18, 1, 1971.

    PubMed  Google Scholar 

  16. Lundbæk K., Jensen V. A., Olsen T. S., Ørskov H., Christensen N. J., Johansen K., Hansen Aa. P., Østerby R.: Diabetes, Diabetic Angiopathy and Growth Hormone — Lancet2, 131, 1970.

    Article  PubMed  Google Scholar 

  17. Merimee T. J., Siperstein M. D., Hall J. D., Fineberg S. E.: Capillary Basement Membrane Structure: a Comparative Study of Diabetic and Sexual Ateliotic Dwarfs — J. clin. Invest.49, 2161, 1970.

    Article  PubMed  CAS  Google Scholar 

  18. Molinatti G. M., Massara F., Strumia E., Pennisi F., Scassellati G. A., Vancheri L.: Radioimmunoassay of Human Growth Hormone — J. nucl. Biol. Med.13 26, 1969.

    PubMed  CAS  Google Scholar 

  19. Muggeo M., Crepaldi G., Fedele D., Tiengo A.: Growth Hormone Secretion in Diabetic Retinopathy — Acta diabet. lat.10, 737, 1973.

    Article  CAS  Google Scholar 

  20. Parker D. C., Rossman L. G.: Sleep Release of Human Growth Hormone in Treated Juvenile Diabetics: Similarity to Normal Subjects and Non-Suppression by Hyperglycemia — Diabetes20, 691, 1971.

    PubMed  CAS  Google Scholar 

  21. Poulsen J. E.: The Houssay Phenomenon in Man: Recovery from Retinopathy in a Case of Diabetes with Simmond’s Disease — Diabetes2, 7, 1953.

    PubMed  CAS  Google Scholar 

  22. Powell E. D. U., Frantz A. G., Rabkin M. T., Field R. A.: Growth Hormone in Relation to Diabetic Retinopathy — New Engl. J. Med.275, 922, 1966.

    Article  PubMed  CAS  Google Scholar 

  23. Ricci V., Molinari G. A., Bonomi L., Zavarise G.: Direct Ultrasonic Irradiation of the Hypophysis in Diabetic Retinopathy — Arch. klin. exp. Ohr.-, Nas.-u. Kehlk. Heilk.204, 237, 1973.

    Article  CAS  Google Scholar 

  24. Roth J., Glick S. M., Yalow R. S., Berson S. A.: Secretion of Growth Hormone: Physiologic and Experimental Modifications — Metabolism12, 577, 1963.

    PubMed  CAS  Google Scholar 

  25. Scott D. J., Dollery C. T., Hill D. W., Hodge J. V., Fraser T. R.: Fluorescein Studies of Diabetic Retinopathy — Brit. med. J.1, 811, 1964.

    Article  PubMed  CAS  Google Scholar 

  26. Sinha M. K., Malik G. P., Rastogi G. K.: Plasma Growth Hormone Response to Insulin-Induced Hypoglycemia in Diabetes Mellitus — Acta diabet. lat.11, 89, 1974.

    Article  CAS  Google Scholar 

  27. Waldhäusl W. K.: Stimulation of Growth Hormone (GH) and Insulin (IRI) Release by Arginine Infusion in Patients with Diabetic Retinopathy — 7th Ann. Meeting Europ. Ass. for the Study of Diabetes, Southampton 1971; abstract # 198.

  28. Wright A. D., Hartog M., Palter H., Tevaarwerk G., Doyle H. F., Arnot R., Joplin G. F., Fraser T. R.: The Use of Yttrium 90 Implantation in the Treatment of Acromegaly — Proc. roy. Soc. Med.63, 221, 1970.

    PubMed  CAS  Google Scholar 

  29. Wright A. O., Kohner E. M., Oakley N. W., Hartog M., Joplin G. F., Fraser T. R.: Serum Growth Hormone Levels and Response of Diabetic Retinopathy to Pituitary Ablation — Brit. med. J.2, 346, 1969.

    Article  PubMed  CAS  Google Scholar 

  30. Zervas N. T., Wesson L. G., Soricelli R. R., Rupp J. J., Field R. A.: Radiofrequency Hypophysectomy for Diabetic Retinopathy — Diabetes16, 538, 1967.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Clinica Medica Generale e Terapia Medica dell’Università, Policlinico, via Giustiniani 2, 35100, Padova, Italy

    Michele Muggeo, Maurizio Molinari, Domenico Fedele, Antonio Tiengo & Gaetano Crepaldi

Authors
  1. Michele Muggeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maurizio Molinari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Domenico Fedele
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonio Tiengo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gaetano Crepaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Research carried out with C.N.R. funds, Contract No. 73.00507.04.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muggeo, M., Molinari, M., Fedele, D. et al. Effect of pituitary ultrasonic treatment on plasma human growth hormone levels in diabetic retinopathy and acromegaly. Acta diabet. lat 12, 137–149 (1975). https://doi.org/10.1007/BF02624732

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02624732

Key-words

Search

Navigation